Business
Green Cures & Botanical Distribution, Inc. Increases Product Placement with the Addition of Blue Plant Farms’ CBD Products on Green Cures Platform
Green Cures & Botanical Distribution, Inc. Increases Product Placement with the Addition of Blue Plant Farms’ CBD Products on Green Cures Platform.
About this update from Green Cures & Botanical Distribution Inc.
[{"type":"text","content":"\nLOS ANGELES, March 14, 2019 (GLOBE NEWSWIRE) -- Green Cures & Botanical Distribution, Inc. (OTC: GRCU) a Colorado corporation (“Green Cures”) is pleased to announce the addition of Blue Plant Farms’ CBD products to the Company’s CBD Platform at www.grcustock.com. Blue Plant Farms has developed proprietary innovative Full Spectrum Hemp Oil products to fulfill the demand in the burgeoning pain relief market. Green Cures is strategically positioning with CBD companies that develop their products with bioavailability of CBDs as their driving force. Blue Plant Farms’ water soluble CBD compound is 90% bioavailable, making their products highly effective and in demand.\n With the addition of Blue Plant Farms’ 10 CBD products, which include 20 mg CBD Blueberry Hemp-Shroom Nootropic Shot, EEZ-Away Blue extra strength w/emu, EEZ-Away Green extra strength w/emu + 300 mg CBD, 25mg CBD K Cup Millennial blend coffee, 25mg CBD K Cup Millennial blend decaf coffee, Sleepy Time Chamomile Hemp Tea K Cup, BluDog 250mg and 500mg naturally duck flavored water soluble hemp oil with c60 topical salve and BluDog 400mg naturally peanut butter/bacon flavored water soluble hemp oil with c60 topical salve Green Cures is further positioning itself for dramatic growth in 2019. In addition to Blue Plant Farms’ products being added to the platform Green Cures also is introducing 1gm CBD Distillate, 1gm CBD Isolate, CBD infused organic dried fruit and a CBD Vegan protein powder, the Blue Plant Farms products with be available on the platform within the next 10 days. Green Cures continues to build out its platform and consolidate Hemp and Cannabis companies to provide an ecosystem of synergistic growth focusing on revenue and EBITDA, with the goal of consolidating and scaling to $15 Million in revenue for FY 2019. With the closing of Green Cures previously announced LOI quickly approaching Green Cures’ management is very confident in meeting and exceeding their FY 2019 goals. In addition to their acquisition model Green Cures will be rolling out a comprehensive marketing campaign with a blended mix of targeted social media, celebrity product endorsements and traditional media outlets to drive revenue growth and brand awareness. About Green Cures & Botanical Distribution, Inc. (OTC PINK: GRCU) Green Cures &...